SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950130-97-005347
Filing Date
1997-11-28
Accepted
1997-11-28 00:00:00
Documents
5
Period of Report
1997-11-25
Items
Item 5: Other events
Item 7: Financial statements and exhibits
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 8-K 8-K 9743
2 CONSENT OF INDEPENDENT AUDITORS EX-23.1 566
3 REPORT OF INDEPENDENT AUDITORS EX-99.1 40692
4 UNAUDITED PRO FORMA COMBINED CONDENSED BALANCE SHEET EX-99.2 18180
5 PRESS RELEASE DATED NOVEMBER, 1997 EX-99.3 5392
  Complete submission text file 0000950130-97-005347.txt   76650
Mailing Address 400 OYSTER POINT BLVD STE 435 SOUTH SAN FRANCSICO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 435 SAN FRANCISCO CA 9402594080 4156350200
ANSAN PHARMACEUTICALS INC (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26422 | Film No.: 97730026
SIC: 2836 Biological Products, (No Diagnostic Substances)